Your browser doesn't support javascript.
loading
Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II).
Van Blarigan, Erin L; Dhruva, Anand; Atreya, Chloe E; Kenfield, Stacey A; Chan, June M; Milloy, Alexandra; Kim, Iris; Steiding, Paige; Laffan, Angela; Zhang, Li; Piawah, Sorbarikor; Fukuoka, Yoshimi; Miaskowski, Christine; Hecht, Frederick M; Kim, Mi-Ok; Venook, Alan P; Van Loon, Katherine.
Affiliation
  • Van Blarigan EL; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.
  • Dhruva A; Department of Urology, University of California, San Francisco, San Francisco, CA, United States.
  • Atreya CE; Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA, United States.
  • Kenfield SA; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
  • Chan JM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.
  • Milloy A; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
  • Kim I; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.
  • Steiding P; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.
  • Laffan A; Department of Urology, University of California, San Francisco, San Francisco, CA, United States.
  • Zhang L; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.
  • Piawah S; Department of Urology, University of California, San Francisco, San Francisco, CA, United States.
  • Fukuoka Y; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.
  • Miaskowski C; University of California, Berkeley, Berkeley, CA, United States.
  • Hecht FM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.
  • Kim MO; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.
  • Venook AP; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.
  • Van Loon K; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
JMIR Cancer ; 8(1): e31576, 2022 Jan 11.
Article in En | MEDLINE | ID: mdl-35014958

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: JMIR Cancer Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: JMIR Cancer Year: 2022 Document type: Article Affiliation country: Country of publication: